Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05883072

Exploring the Effectiveness of AI Generative Models for Diabetic Patients

Status
Recruiting
Phase
Study type
Observational
Enrollment
300 (estimated)
Sponsor
Pakistan Council of Scientific and Industrial Research · Academic / Other
Sex
All
Age
18 Years – 100 Years
Healthy volunteers
Not accepted

Summary

We plan to explore the usability of Generative AI-Chatbot for Diabetic Patient

Detailed description

Diabetes is rapidly spreading, affecting a significant number of adults, with a staggering total of 537 million diabetic individuals. This condition gives rise to various complications that can lead to diabetic retinopathy, foot ulcers, cardiac problems, and kidney damage. However, many of these complications can be mitigated by providing patients with accurate information concerning their diet, stress management, and weight control. The recent advancements in Generative Artificial Intelligence-based chatbots have demonstrated their efficacy as intelligent assistants across various aspects of human life. In this study, we aim to assess the effectiveness of these Language Models in assisting patients. Our research plan entails the interaction between patients and chatbots like ChatGPT, both with and without human support, followed by evaluations of these interactions by specialists. Additionally, we will gather feedback from patients regarding their experiences and perceptions of the chatbot interactions.

Conditions

Interventions

TypeNameDescription
BEHAVIORALExploring AI-ChatbotAll participants will be provided access to AI-Chatbot and will be asked to enquire their daily life problems related to diabetes. They will also be asked to review the replies of the Chatbot after their interaction.

Timeline

Start date
2023-01-05
Primary completion
2024-12-30
Completion
2026-12-31
First posted
2023-05-31
Last updated
2023-06-05

Locations

1 site across 1 country: Pakistan

Source: ClinicalTrials.gov record NCT05883072. Inclusion in this directory is not an endorsement.